End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.36 CNY | -1.21% | -0.19% | -6.35% |
May. 30 | Hengrui Pharmaceuticals Gets Nod to Trial Vitiligo Drug | MT |
May. 27 | China Grants Clinical Trial Approval for Anti-Cancer Injections | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.35% | 37.19B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 600276 Stock
- News Jiangsu Hengrui Medicine Co., Ltd.
- Hengrui Pharmaceuticals to Resubmit Marketing Application for Liver Cancer Drug Combination to US FDA